Cargando…
Evidence-based medicine and clinical fluorodeoxyglucose PET/MRI in oncology
Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) is a hybrid of two technologies each with its own evidence for clinical effectiveness. This article amalgamates evidence for clinical effectiveness of fluorodeoxyglucose (FDG) PET/CT and MRI as separate modalities with current evidenc...
Autores principales: | Miles, Kenneth, McQueen, Liam, Ngai, Stanley, Law, Phillip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650106/ https://www.ncbi.nlm.nih.gov/pubmed/26578188 http://dx.doi.org/10.1186/s40644-015-0053-1 |
Ejemplares similares
-
Evidence-based medicine: clinical utility of PET in oncology
por: Miles, K. A.
Publicado: (2015) -
Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review
por: Ciliberto, Mario, et al.
Publicado: (2013) -
Takayasu arteritis detected by PET/MRI with (18)F-fluorodeoxyglucose
por: Takeishi, Yasuchika, et al.
Publicado: (2018) -
Multiparametric PET/CT in oncology
por: Singh, Dalveer, et al.
Publicado: (2012) -
Cardiac imaging with (18)F-fluorodeoxyglucose PET/MRI in hypertrophic cardiomyopathy
por: Takeishi, Yasuchika, et al.
Publicado: (2016)